Understanding how the bladder environment influences cancer development and progression
The stromal microenvironment as a co-organizer of bladder carcinogenesis and progression
This study is looking at how the environment around the bladder affects bladder cancer, especially to understand why some cases come back but don’t get worse, while others do, so that doctors can find better ways to tailor treatments for patients based on their individual risks.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Methodist Hospital Research Institute NIH-funded |
| Lab location | 1 site (Houston, United States) |
| Project ID | NIH-10708892 on NIH RePORTER |
What this research studies
This research investigates the role of the bladder's microenvironment in the development and progression of bladder cancer. It aims to identify the mechanisms that differentiate between non-muscle-invasive bladder cancer that recurs but does not progress and those that advance to muscle-invasive disease. By exploring these mechanisms, the research seeks to develop biomarkers that can help stratify patients based on their risk of progression. This approach could lead to more personalized treatment strategies for patients with bladder cancer.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with non-muscle-invasive bladder cancer.
Not a fit: Patients with muscle-invasive bladder cancer or those without a diagnosis of bladder cancer may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved risk stratification and treatment options for patients with bladder cancer.
How similar studies have performed: Other research has shown promise in understanding the tumor microenvironment's role in cancer progression, suggesting that this approach could yield valuable insights.
Where this research is happening
Houston, United States
- Methodist Hospital Research Institute — Houston, United States (Active)
Researchers
- Principal investigator: Chan, Keith Syson — Methodist Hospital Research Institute
- Study coordinator: Chan, Keith Syson
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.